脉搏波幅度下降指数:阻塞性睡眠呼吸暂停心血管风险的生物标志物
研究在三个前瞻性队列(HypnoLaus N=1,941、PLSC N=6,367、ISAACC N=692)中,从基于脉搏血氧的光电容积描记信号提取脉搏波幅度下降(PWAD)指数(睡眠中每小时>30%的PWAD次数),按有无OSA(AHI≥15/h或<15/h)及PWAD指数中位数分组,主要终点为复合心血管事件。校正心血管危险因素后,低PWAD且OSA组心血管事件发生率高于高PWAD且OSA组及无OSA组:HypnoLaus HR 2.16(1.07-4.34,P=0.031)和2.35(1.12-4.93,P=0.024);PLSC HR 1.36(1.13-1.63,P=0.001)和1.44(1.06-1.94,P=0.019)。ISAACC中低PWAD且OSA未治疗组事件复发率高于无OSA组(HR 2.03,1.08-3.81,P=0.028)。PLSC和HypnoLaus中,连续PWAD指数每增加10次/小时仅OSA患者心血管事件风险负相关(HR 0.85,0.73-0.99,P=0.031;HR 0.91,0.86-0.96,P<0.001),无OSA组及ISAACC队列不显著。结论提示低PWAD指数反映自主神经和血管反应性差,与OSA患者更高心血管风险独立相关。
要点
- 低PWAD指数且OSA患者心血管事件风险高于高PWAD且OSA组:HypnoLaus HR 2.16(1.07-4.34,P=0.031),PLSC HR 1.36(1.13-1.63,P=0.001)。
- 低PWAD指数且OSA患者心血管事件风险高于无OSA组:HypnoLaus HR 2.35(1.12-4.93,P=0.024),PLSC HR 1.44(1.06-1.94,P=0.019)。
- ISAACC中低PWAD且OSA未治疗组心血管事件复发率高于无OSA组(HR 2.03,1.08-3.81,P=0.028)。
- PLSC和HypnoLaus中,连续PWAD指数每增加10次/小时,仅OSA患者心血管事件风险负相关(HR 0.85,0.73-0.99,P=0.031;HR 0.91,0.86-0.96,P<0.001)。
- 无OSA组及ISAACC队列中连续PWAD指数与心血管事件的关联不显著。
适用人群与场景
- 三个前瞻性队列人群:HypnoLaus(N=1,941)、Pays-de-la-Loire睡眠队列(PLSC;N=6,367)、ISAACC(N=692)。
- 按有无OSA(AHI≥15/h为有OSA,<15/h为无OSA)及PWAD指数中位数分为亚组。
诊断标准与关键阈值
- OSA定义:呼吸暂停低通气指数(AHI)≥15次/小时。
- PWAD指数:睡眠中每小时脉搏波幅度下降>30%的次数。
- 按PWAD指数中位数分为低PWAD组和高PWAD组。
研究设计与关键结果
- 研究设计:三个前瞻性队列(HypnoLaus N=1,941、PLSC N=6,367、ISAACC N=692),从基于脉搏血氧的光电容积描记信号提取PWAD指数,主要终点为复合心血管事件发生率。
- 校正心血管危险因素后,低PWAD且OSA组心血管事件发生率高于高PWAD且OSA组:HypnoLaus HR 2.16(95%CI 1.07-4.34,P=0.031);PLSC HR 1.36(95%CI 1.13-1.63,P=0.001)。
- 低PWAD且OSA组心血管事件发生率高于无OSA组:HypnoLaus HR 2.35(95%CI 1.12-4.93,P=0.024);PLSC HR 1.44(95%CI 1.06-1.94,P=0.019)。
- ISAACC队列中,低PWAD且OSA未治疗组心血管事件复发率高于无OSA组(HR 2.03,95%CI 1.08-3.81,P=0.028)。
- PLSC和HypnoLaus队列中,连续PWAD指数每增加10次/小时,仅OSA患者心血管事件风险负相关(PLSC HR 0.85,95%CI 0.73-0.99,P=0.031;HypnoLaus HR 0.91,95%CI 0.86-0.96,P<0.001)。
- 无OSA组和ISAACC队列中,连续PWAD指数与心血管事件的关联不显著。
证据类型、等级与局限
- 证据类型:三个前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在OSA患者中,低PWAD指数反映自主神经和血管反应性差,独立关联更高的心血管风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: It is currently unclear which patients with obstructive sleep apnea (OSA) are at increased cardiovascular risk. Objective: To investigate the value of pulse wave amplitude drops (PWADs), reflecting sympathetic activations and vasoreactivity, as a biomarker of cardiovascular risk in OSA. Methods: PWADs were derived from pulse oximetry-based photoplethysmography signals in three prospective cohorts: HypnoLaus (N = 1,941), the Pays-de-la-Loire Sleep Cohort (PLSC; N = 6,367), and "Impact of Sleep Apnea syndrome in the evolution of Acute Coronary syndrome. Effect of intervention with CPAP" (ISAACC) (N = 692). The PWAD index was the number of PWADs (>30%) per hour during sleep. All participants were divided into subgroups according to the presence or absence of OSA (defined as ⩾15 or more events per hour or <15/h, respectively, on the apnea-hypopnea index) and the median PWAD index. Primary outcome was the incidence of composite cardiovascular events. Measurements and Main Results: Using Cox models adjusted for cardiovascular risk factors (hazard ratio; HR [95% confidence interval]), patients with a low PWAD index and OSA had a higher incidence of cardiovascular events compared with the high-PWAD and OSA group and those without OSA in the HypnoLaus cohort (HR, 2.16 [1.07-4.34], P = 0.031; and 2.35 [1.12-4.93], P = 0.024) and in the PLSC (1.36 [1.13-1.63], P = 0.001; and 1.44 [1.06-1.94], P = 0.019), respectively. In the ISAACC cohort, the low-PWAD and OSA untreated group had a higher cardiovascular event recurrence rate than that of the no-OSA group (2.03 [1.08-3.81], P = 0.028). In the PLSC and HypnoLaus cohorts, every increase of 10 events per hour in the continuous PWAD index was negatively associated with incident cardiovascular events exclusively in patients with OSA (HR, 0.85 [0.73-0.99], P = 0.031; and HR, 0.91 [0.86-0.96], P < 0.001, respectively). This association was not significant in the no-OSA group and the ISAACC cohort. Conclusions: In patients with OSA, a low PWAD index reflecting poor autonomic and vascular reactivity was independently associated with a higher cardiovascular risk.
参考来源
- Solelhac G, Sánchez-de-la-Torre M, Blanchard M, et al. Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2023. PMID: 37017487. doi:10.1164/rccm.202206-1223OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。